Cesca’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases. Read more

1,055 Followers on Owler
1,055 Followers on Owler
1,055 Followers on Owler
1,055 Followers on Owler

Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases. Read more

Chris Xu's photo - Chairman & CEO of Cesca

Chairman & CEO

Chris Xu

CEO Approval Rating

77/100

Founded:

1986

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Caladrius Biosciences is the biggest rival of Cesca. Caladrius Biosciences is headquartered in Basking Ridge, New Jersey, and was founded in 2006. Like Cesca, Caladrius Biosciences also operates in the Biotechnology space. Caladrius Biosciences generates 122% the revenue of Cesca.

Osiris Therapeutics is Cesca's #2 competitor. Osiris Therapeutics is a Private company that was founded in Columbia, Maryland in 1992. Like Cesca, Osiris Therapeutics also works within the Biotechnology sector. Osiris Therapeutics has 307 more employees vs. Cesca.

Mesoblast Limited has been one of Cesca's top competitors. Mesoblast Limited's headquarters is in Melbourne, Victoria, and was founded in 2004. Mesoblast Limited operates in the Biotechnology industry. Mesoblast Limited generates 246% of Cesca's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 53 a good estimate for Cesca's Employee count?

Acquisitions

No recent acquisitions found related to Cesca

Cesca Funding History

$26.3M$41.3M$56.3M$61.8M$62.6M

Since Cesca was founded in 1986, it has participated in 6 rounds of funding. In total Cesca has raised $62.6M. Cesca's last funding round was on Jan 2019 for a total of $800.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2019
$800K
-
Equity
May 2018
$5.5M
-
Equity
Feb 2016
$15M
Equity
Aug 2015
$15M
-
Debt
Aug 2014
$15M
-

Since Cesca was founded in 1986, it has participated in 6 rounds of funding. In total Cesca has raised $62.6M. Cesca's last funding round was on Jan 2019 for a total of $800.0K

Investments

No recent investments found related to Cesca

Cesca News

October 23, 2019The Business Journals: Sacramento

Cesca to launch immune cell banking service

Rancho Cordova-based Cesca Therapeutics Inc. says it's launching a joint venture to create a blood ba... See more »
October 2, 2019BioSpace

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous c... See more »
September 11, 2019marketexclusive

CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Files An 8-K Regulation FD Disclosure

On September 10, 2019, Cesca Therapeutics Inc., (the “Company”) provided an update to its corporate p... See more »
September 9, 2019BioSpace

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

The Company will receive a $2 million upfront distribution fee, and future market support for grantin... See more »
August 16, 2019BioPortfolio

Cesca Therapeutics Inc KOOL Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $125

Cesca Therapeutics Inc KOOL Financial and Strategic SWOT Analysis Review provides you an indepth stra... See more »

Cesca Press Releases

June 4, 2019PR Newswire

Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock

RANCHO CORDOVA, Calif., June 4, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market... See more »
May 7, 2019PR Newswire

Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14

RANCHO CORDOVA, Calif., May 7, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market ... See more »
February 11, 2019StreetInsider

ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark

RANCHO CORDOVA, Calif., Feb. 11, 2019 /PRNewswire/ -- ThermoGenesis Corp, a private corporation owned... See more »
November 19, 2018PR Newswire

Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking

RANCHO CORDOVA, Calif., Nov. 19, 2018 /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a marke... See more »
November 15, 2018central charts

Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update

RANCHO CORDOVA, Calif., Nov. 14, 2018 /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a marke... See more »
September 13, 2018StreetInsider

Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018

Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-car... See more »
September 5, 2018PR Newswire

Cesca Therapeutics Provides Commercialization Update For Its X-Series Product Line

RANCHO CORDOVA, Calif., Sept. 5, 2018 /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a marke... See more »

Cesca Videos

Social Media

Headquarters

2711 Citrus Road

Rancho Cordova, California95742

1-916-858-5100

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases. Cesca was founded in 1986. Cesca's headquarters is located in Rancho Cordova, California, USA 95742. It has r...

CEO

Cesca's Chairman & CEO, Chris Xu, currently has an approval rating of 77%. Cesca's primary competitors are Caladrius Biosciences, Osiris Therapeutics & Mesoblast Limited.

Website

cescatherapeutics.com

Frequently Asked Questions about Cesca

  1. When was Cesca founded?

    Cesca was founded in 1986
  2. Who is Cesca's CEO?

    Cesca's CEO is Chris Xu
  3. How much revenue does Cesca generate?

    Cesca generates $13.1M in revenue
  4. How much funding does Cesca have?

    Cesca has historically raised $62.6M in funding
  1. Where is Cesca's headquarters?

    Cesca's headquarters is in Rancho Cordova California, USA
  2. How many employees does Cesca have?

    Cesca has 53 employees
  3. What sector does Cesca operate in?

    Cesca is in Biotechnology
  4. Who are Cesca's competitors?

    Cesca's top competitors are Caladrius Biosciences, Osiris Therapeutics, Mesoblast Limited